Treasure Valley Medical Research

What Treasure Valley Medical Research does

Treasure Valley Medical Research (TVMR) is a privately-held, single-site clinical research center headquartered at 1000 N Curtis Road, Suite 102 in Boise, Idaho, founded in 2017. The company conducts Phase II-IV outpatient clinical trials sponsored by pharmaceutical and biotech firms across nine therapeutic areas: asthma, atopic dermatitis, celiac disease, chronic urticaria, Crohn's disease, eosinophilic esophagitis, hidradenitis suppurativa, nasal polyps, and vitiligo (including a pediatric vitiligo protocol). TVMR serves two customer constituencies: (1) pharma and biotech sponsors who pay for trial execution, and (2) individual patients in the Treasure Valley who enroll at no cost and may receive compensation for time and participation. The site's core technology stack is conventional clinical research infrastructure rather than a software platform, comprising a CLIA-certified on-site laboratory, temperature-controlled and locked drug and sample storage, spirometry and ECG diagnostic equipment, and emergency response capabilities including AED and emergency medications.

TVMR's revenue model is contract-based, with sponsors paying per-patient enrollment fees, study completion milestones, and procedure reimbursements for data collection, patient monitoring, and regulatory compliance documentation. Patient pricing is structured as no-cost participation with compensation, billed to sponsors rather than participants or insurers. The go-to-market is community-led and recruitment-driven: patients are acquired through condition-specific website pages, a Facebook presence, Google Reviews reputation (4.9 stars across 33+ reviews), direct coordinator contact, and referrals from healthcare providers including a strategic partnership with The Allergy Group that supplies allergy, respiratory, and immunology trial candidates.

The organization is staffed by a board-certified Principal Investigator (Dr. Neetu Talreja, Allergy & Immunology), Sub-Investigators including Dr. Akshay Gupta (Gastroenterology, University of Michigan-trained), a Site Director and Lead-CCRC with 20+ years of experience, multiple Clinical Research Coordinators, a Lab Tech Coordinator, Regulatory Affairs Manager, Accountant, Recruitment Coordinator, and Community Engagement Specialist. No public funding rounds, acquisitions, or revenue figures have been disclosed, and ownership is not publicly detailed.

Name

Treasure Valley Medical Research

Legal name

Treasure Valley Medical Research

Website

https://tvmedresearch.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Treasure Valley Medical Research is a single-site, Boise-based outpatient clinical research center conducting Phase II-IV trials across nine therapeutic areas for pharmaceutical and biotech sponsors, while offering no-cost study participation to Treasure Valley patients with dermatologic, gastrointestinal, allergic, and immune-mediated conditions.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Clinical research services
• Outpatient clinical trials
• Phase II-IV studies
• Clinical trial recruitment
• Therapeutic area research

Headquarters

HQ city

Boise

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Sponsorship Revenue: TVMR conducts Phase II-IV outpatient clinical trials sponsored by pharmaceutical companies and biotech firms. Revenue comes from per-patient enrollment fees, study completion milestones, and procedure reimbursements. Sponsors pay for data collection, patient monitoring, and regulatory compliance documentation.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Treasure Valley Medical Research (TVMR) operates a single-facility clinical research center in Boise, Idaho that conducts Phase II-IV outpatient clinical trials sponsored by pharmaceutical and biotech companies. The site recruits local Treasure Valley patients into studies across therapeutic areas including asthma, atopic dermatitis, celiac disease, chronic urticaria, Crohn's disease, eosinophilic esophagitis, hidradenitis suppurativa, nasal polyps, and vitiligo, providing on-site clinical research coordination, CLIA-certified laboratory processing, regulatory compliance, and patient monitoring under board-certified principal investigators.

Product overview

Treasure Valley Medical Research (TVMR) operates as a single-facility clinical research center offering Phase II-IV outpatient clinical trials. The company provides access to investigational medications, biologics, and novel therapies across multiple therapeutic areas including immune-mediated diseases, dermatology, allergy & asthma, gastrointestinal conditions, and inflammatory disorders. The product portfolio consists of nine distinct clinical studies covering Asthma, Atopic Dermatitis, Vitiligo, Hidradenitis Suppurativa, Nasal Polyps, Chronic Urticaria, Crohn's Disease, Eosinophilic Esophagitis, and Celiac Disease. Participants receive study-related care at no cost with compensation for time and participation, supported by a CLIA-certified clinical laboratory and specialized medical equipment including spirometry and ECG capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Asthma Clinical Trial Clinical study for children and adults with asthma, offering participation in evaluating new medications and therapies for asthma management.
• Atopic Dermatitis Clinical Trial Clinical study for children and adults with atopic dermatitis (eczema), evaluating investigational treatments for skin inflammation and symptom relief.
• Celiac Disease Clinical Trial Clinical study for adults 18+ with celiac disease, investigating new therapeutic approaches for this autoimmune digestive condition.
• Chronic Spontaneous and Inducible Urticaria Clinical Trial Clinical study for adults 18+ with chronic spontaneous or inducible urticaria, evaluating new treatment options for symptom management.
• Crohn's Disease Clinical Trial Clinical study for adults 18+ with Crohn's disease, investigating new medications and biologics for inflammatory bowel disease management.
• Eosinophilic Esophagitis Clinical Trial Clinical study for adults 18+ with eosinophilic esophagitis, evaluating treatments for chronic swallowing difficulties caused by esophageal inflammation.
• Hidradenitis Suppurativa Clinical Trial Clinical study for children and adults with hidradenitis suppurativa, evaluating investigational therapies for this chronic inflammatory skin condition.
• Nasal Polyps Observation Study Observation study for children and adults with chronic rhinosinusitis and nasal polyps, documenting disease progression and treatment outcomes.
• Vitiligo Clinical Trial Pediatric clinical study for children with vitiligo, investigating potential treatments for repigmentation and disease management.

Quantifiable outcome

• 4.9-star Google rating from over 33 patient reviews
• +1 more outcomes

Named customers4 records

Segments10 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• The Allergy GroupcoreStrategic or Co-development PartnerTVMR collaborates closely with The Allergy Group, a respected clinic serving the Treasure Valley, to expand research opportunities for patients with allergic, respiratory, and immune-related diseases. This partnership provides a pipeline of potential study participants and integrates clinical care with research opportunities.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Accel Research Sites: Accel Research Sites is a multi-specialty SMO network operating outpatient clinical trial sites. Comparable to TVMR in therapeutic breadth, outpatient Phase II-IV trial focus, and community-based patient recruitment.
• Flourish Research: Flourish Research operates integrated clinical research sites across the U.S. with a multi-specialty outpatient model. Directly comparable to TVMR in therapeutic diversity (including dermatology, GI, and respiratory), outpatient trial conduct, and sponsor-driven revenue.
• Benchmark Research: Benchmark Research is a community-based clinical research site operator running multi-therapeutic Phase II-IV trials. Similar to TVMR in single/multi-site outpatient model, sponsor-funded revenue, and patient recruitment focus.
• Velocity Clinical Research: Velocity Clinical Research operates a large multi-site SMO network across the U.S. running Phase II-IV trials in multiple therapeutic areas. Highly comparable business model to TVMR — both run community-based outpatient research sites with multi-specialty coverage and sponsor revenue from per-patient fees.
• Clinical Trials of Texas: Clinical Trials of Texas is a community-based research site conducting multi-therapeutic outpatient trials. Directly comparable in therapeutic mix (including dermatology, GI, and respiratory), outpatient site model, and contract revenue from sponsors.
• CTI Clinical Trial & Consulting Services: CTI is a mid-sized CRO and clinical research site operator with multi-therapeutic capabilities. Comparable to TVMR in running sponsor-funded clinical trials across inflammatory, immune-mediated, and specialty disease areas.

Broad incumbents

• ICON plc: ICON is a major global CRO with site management operations across therapeutic areas. Comparable in serving pharma/biotech sponsors running trials in immunology, dermatology, and GI — many of TVMR's target indications.
• IQVIA: IQVIA is one of the largest global CROs with extensive site management capabilities. Relevant as a broad incumbent — TVMR could potentially serve as a community site within IQVIA-managed trial networks, and both target the same pharmaceutical sponsor clients.
• Syneos Health: Syneos Health is a large biopharmaceutical solutions organization with clinical research site and CRO capabilities. Comparable as a broad industry peer in therapeutic trial delivery for immune-mediated and inflammatory conditions.
• Medpace: Medpace is a global mid-to-large CRO running Phase II-IV trials across therapeutic areas including many of the same indications as TVMR (GI, dermatology, respiratory). Comparable as an indirect peer — both serve the same pharma/biotech sponsor base, but Medpace operates at much greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/TVMResearch
• LinkedInlinkedin.com/company/treasure-valley-medical-research

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Treasure Valley Medical Research